Zdrowie i gospodarka · 25/09/2001

FDA Releases Draft Guidance on Stability Testing Designs for Pharmaceuticals

The FDA has made available a draft guidance document outlining reduced stability testing designs, known as bracketing and matrixing, for pharmaceuticals, as part of the International Conference on Harmonisation's efforts to standardize pharmaceutical regulations.